| Original language | English (US) |
|---|---|
| Pages (from-to) | 1076-1078 |
| Number of pages | 3 |
| Journal | JACC: Cardiovascular Imaging |
| Volume | 14 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2021 |
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Cardiology and Cardiovascular Medicine
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Impact of Chronic Total Occlusion Revascularization on Left Ventricular Function Assessed by Cardiac Magnetic Resonance. / Megaly, Michael; Brilakis, Emmanouil S.; Abdelsalam, Mahmoud; Pershad, Ashish; Saad, Marwan; Garcia, Santiago; Burke, M. Nicholas; Schelbert, Erik B.; Bucciarelli-Ducci, Chiara; Cavalcante, João L.
In: JACC: Cardiovascular Imaging, Vol. 14, No. 5, 05.2021, p. 1076-1078.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Impact of Chronic Total Occlusion Revascularization on Left Ventricular Function Assessed by Cardiac Magnetic Resonance
AU - Megaly, Michael
AU - Brilakis, Emmanouil S.
AU - Abdelsalam, Mahmoud
AU - Pershad, Ashish
AU - Saad, Marwan
AU - Garcia, Santiago
AU - Burke, M. Nicholas
AU - Schelbert, Erik B.
AU - Bucciarelli-Ducci, Chiara
AU - Cavalcante, João L.
N1 - Funding Information: Dr. Brilakis has received consulting or speaker honoraria from Abbott Vascular, the American Heart Association (associate editor of Circulation), Biotronik, Boston Scientific, Cardiovascular Innovations Foundation, CSI, Elsevier, GE Healthcare, InfraRedx, Medtronic, and Teleflex; is on the Board of Directors of Cardiovascular Innovations Foundation; has received research support from Regeneron and Siemens; and holds shares in MHI Ventures. Dr. Garcia has received consulting for Surmodics, Osprey Medical, Medtronic, Edwards Lifesciences, and Abbott Vascular; institutional grant support from Edwards Lifesciences, Abbott Vascular, and BSCI; and honoraria from the American College of Cardiology. Dr. Burke has received holding shares in Egg Medical, and MHI Ventures; and has been a speaker for Opsens Medical. Dr. Cavalcante has received consulting for Abbott Vascular, Boston Scientific, Medtronic, 4Tech, and Edwards Lifesciences; grant support from Edwards Lifesciences, Medtronic, Abbott Vascular, Boston Scientific, and Circle Cardiovascular Imaging; and has received speaker honoraria from Siemens Healthineers and Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
PY - 2021/5
Y1 - 2021/5
UR - http://www.scopus.com/inward/record.url?scp=85097379246&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85097379246&partnerID=8YFLogxK
U2 - 10.1016/j.jcmg.2020.10.012
DO - 10.1016/j.jcmg.2020.10.012
M3 - Letter
C2 - 33221235
AN - SCOPUS:85097379246
VL - 14
SP - 1076
EP - 1078
JO - JACC: Cardiovascular Imaging
JF - JACC: Cardiovascular Imaging
SN - 1936-878X
IS - 5
ER -